KRTL BioTech

Latest News on private equity markets

Britain says health service, drug prices not up for negotiation in U.S. talks

Britain said on Monday that the price its state funded National Health Service (NHS) pays for drugs would not be on the table in trade talks with the United States.



5 years ago

Factbox: What Britain wants from a trade deal with the United States

Britain outlined its negotiating mandate for talks with the United States on Monday, with the hope of reducing tariffs while shielding the public health service and protecting food and animal welfare standards.



5 years ago

UK wants a big U.S. trade deal but health and food standards not up for grabs

Britain said on Monday it will seek to achieve huge gains by removing barriers to trade with the United States in talks for a deal this year but its health service would not be on the table in talks.



5 years ago

More traffic, night lights show China's factories restart as new virus cases drop

Nearly 300 million people have gone back to work in China since the Lunar New Year break as more companies restart business and coronavirus travel restrictions ease, although many small firms are still struggling to find enough workers to run plants.



5 years ago

Amazon's fight against $277 million EU tax order kicks off in court on Thursday

Amazon will on Thursday seek to overturn an EU order to repay about 250 million euros ($277 million) in back taxes to Luxembourg at Europe's second-highest court, one of a series of high-profile cases marking the bloc's crackdown on unfair tax deals.



5 years ago

Amazon, Walmart, the Secret Battle for FinTech Supremacy: Part II

Highradius | Anuj Saxena | Flashback to June 2018 Digital to Physical, Physical to Digital and Customer Segments As Walmart rushes to become Amazon before Amazon can become Walmart, the impressive way Walmart has addressed the problem reminds me of a quote from Jim Collins in his bestseller “Good to Great”: “The good-to-great companies displayed two

5 years ago

Gold has 'immunity' to coronavirus, Goldman says

As the coronavirus outbreak continues to hammer stocks, Goldman Sachs said gold has immunity to the virus.

5 years ago

Wharton's Jeremy Siegel sees a 'short, quick recession' due to the coronavirus

"We could really have a short, quick recession," Wharton School finance professor Jeremy Siegel.

5 years ago

Big Data Promises Better Deals. But for Whom?

Wired | Gilad Edelman | Feb 28, 2020 Antitrust regulators say they’re interested in data-driven mergers. Intuit’s $7 billion deal to buy Credit Karma will show how serious they are. The announcement earlier this week that Intuit, the financial software giant, would be buying the personal finance company Credit Karma for $7 billion was striking.

5 years ago

Advent/Cinven-led consortium to spend 'billions' on expanding Thyssenkrupp Elevator

(This March 1 story has been refiled to show that the consortium is led by Advent and Cinven)



5 years ago

Here's how to maximize traditional and Roth retirement savings

Tax treatment varies among types of retirement accounts, which means the investments you hold in each of them should ideally capitalize on those differences, experts say.

5 years ago

Trump presses U.S. Federal Reserve to cut rates

U.S. President Donald Trump on Monday reiterated his call for the U.S. central bank to lower interest rates, tweeting that the Federal Reserve has been "slow to act" and should be more aggressive.



5 years ago

Futures traders bet on big U.S. rate cut by Fed this month

The U.S. central bank will deliver a big dose of stimulus this month in a bid to protect the world's biggest economy from the impact of the spread of the new coronavirus, traders of futures contracts tied to the Federal Reserve's policy rate are betting.



5 years ago

Wall Street up in choppy trade, stimulus measures take center stage

U.S. stock indexes were slightly higher in choppy trading on Monday, as investors assessed the efficacy of further monetary stimulus amid the growing economic impact of the coronavirus outbreak.



5 years ago

Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline

Gilead Sciences Inc said on Monday it would buy Forty Seven Inc for $4.9 billion in cash, adding an experimental treatment that targets blood cancer to its portfolio of oncology drugs.



5 years ago